Anxiety and Depression May be Prevalent in Children with Comorbid Autism and ADHD

By |2018-04-19T09:16:58-07:00April 16th, 2018|We Know Psychiatry|

Children with comorbid autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of anxiety and mood disorders, a cross-sectional analysis has shown. “Our study supports that anxiety and mood disorders, although highly prevalent in those with ASD alone, are even more prevalent in individuals who have [...]

ADHD Redux: Overdiagnosed and Overtreated, or Misdiagnosed and Mistreated?

By |2017-12-04T09:08:38-08:00December 4th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

By Michael J. Manos, Kimberly Giuliano, and Eric Geyer The Affordable Care Act of 2010 sought to transform medical care in the United States from procedures to performance, from acute episodes of illness to integrated care across the lifespan, and from inefficient care to efficient and affordable care with measurable outcomes. At [...]

FDA Clears New Methylphenidate Formulation for ADHD

By |2021-11-11T17:07:13-08:00June 20th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The US Food and Drug Administration (FDA) has approved a new formulation of methylphenidate for children with attention-deficit/hyperactivity disorder (ADHD). Cotempla XR-ODT (Neos Therapeutics Inc) is the first and only methylphenidate extended-release orally disintegrating tablet for the treatment of ADHD in patients aged 6 to 17 years, the company said [...]

Experimental ADHD Drugs Aimed at Aggression, Genetic Targets

By |2021-11-11T17:07:48-08:00June 14th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

MIAMI – Medications in development for the treatment of attention-deficit/hyperactivity disorder (ADHD) target specific behaviors, such as impulsive aggression, and genes that involve the glutamatergic network, new research shows. In the first of two studies presented here at the American Society of Clinical Pharmacology (ASCP), researchers reported on improvements in [...]

The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5

By |2021-11-11T17:13:34-08:00April 8th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Berk Ustun, Lenard A. Adler, Cynthia Rudin, et al Key Points Question Can a brief screening scale based on patient responses to structured questions detect DSM-5 adult attention-deficit/hyperactivity disorder in the general population? Findings A new machine-learning algorithm was used to build a screening scale from responses to 6 questions [...]

Personality Traits Tied to Genome Areas & Mental Illness

By |2021-11-11T17:15:56-08:00December 20th, 2016|Brief Bulletins from the Field, We Know Psychiatry|

Researchers have identified six regions of the human genome that are significantly linked to personality traits, and some show significant correlations to certain psychiatric disorders as well. The study, conducted by researchers at the University of California San Diego School of Medicine, is based on a meta-analysis of genome-wide association [...]

New Evidence Suggests that Children with ADHD and Autistic Spectrum Disorder may have lower Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels

By |2016-05-31T13:36:02-07:00May 31st, 2016|We Know Psychiatry|

By Natalie Parletta, Theophile Niyonsenga, and Jacques Duff Abstract Background There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels. Objectives This study investigated whether erythrocyte [...]

Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-onset Syndrome

By |2016-05-31T13:16:56-07:00May 31st, 2016|We Know Psychiatry|

By Arthur Caye; Thiago Botter-Maio Rocha, MD, MSc; Luciana Anselmi, PhD; Joseph Murray, PhD; Ana M. B. Menezes, PhD; Fernando C. Barros, PhD; Helen Gonçalves, PhD; Fernando Wehrmeister, PhD; Christina M. Jensen, MSc; Hans-Christoph Steinhausen, MD, PhD, DMSc; James M. Swanson, PhD; Christian Kieling, MD, PhD; Luis Augusto Rohde, MD, PhD ABSTRACT Importance  The requirement of a childhood onset has always been a key criterion for the diagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults, but [...]

Shire Presents New Research into Binge Eating Disorder and ADHD

By |2016-05-16T18:27:47-07:00May 16th, 2016|We Know Psychiatry|

Pharmaceutical heavyweight, Shire, best known in the US for its ADHD medications, presented new research on Binge Eating Disorder (B.E.D.) and Attention-Deficit/Hyperactivity Disorder (ADHD) at the American Psychiatric Association (APA) in Atlanta, GA, "demonstrating its ongoing commitment to furthering the understanding and management of psychiatric disorders," the company said in a [...]

Awesome Apps for Kids/Teens with ADHD

By |2016-02-01T16:36:22-08:00February 1st, 2016|We Know Psychiatry|

Let’s face it. We live in the age of technology. Things that were learned through books, lectures, and hand-written practices when we were kids are now being learned through games, apps, and videos by the kids of this generation. Even their leisure time is spent differently than ours. For ADHD [...]

Title

Go to Top